glutathione reductase deficiency vitamin antioxidant system. a Schematics for the reduction of An Open-Label Case Series of
Description
Therefore, ACSL4 inhibitor might be a potential therapeutic drug for ARDS

Arch Biochem Biophys 704:108869

doi:10.1016/j.ecoenv.2024.117069

We identified two parkin-dependent effects on glutathione metabolism
